GTS Securities’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

GTS Securities’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,000	Closed	-$247K	–	4613
2023 Q4	$247K	Buy	+15,000	New	+$236K	﹤0.01%	3386

GTS Securities's ORTX Position: Q1 2024 in Review

GTS Securities sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 15,000 shares — an estimated $247K sold.

GTS Securities first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $247K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

GTS Securities reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
GTS Securities sold 15,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $247K.
GTS Securities first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
GTS Securities's Orchard Therapeutics plc American Depositary Shares position peaked at $247K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on GTS Securities's 13F filing for Q1 2024, filed 15 May 2024.